KASL clinical practice guidelines for management of chronic hepatitis B
INTRODUCTION Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a threat to public health due to its high morbidity and disease-related mortality. Since the latest version of clinical practice guidelines of CHB in 2018 by the Korean Association for the Study of...
Saved in:
Published in | Clinical and molecular hepatology Vol. 28; no. 2; pp. 276 - 331 |
---|---|
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Association for the Study of the Liver
01.04.2022
The Korean Association for the Study of the Liver 대한간학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2287-2728 2287-285X 2287-285X |
DOI | 10.3350/cmh.2022.0084 |
Cover
Loading…
Abstract | INTRODUCTION Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a threat to public health due to its high morbidity and disease-related mortality. Since the latest version of clinical practice guidelines of CHB in 2018 by the Korean Association for the Study of the Liver (KASL), many studies related to hepatitis B virus (HBV) have been published, raising the need to revise the recommendations reflecting the most up-to-date information on management of CHB. The KASL will continue to update part or all of these guidelines based on publication of new study results. [...]revision of the guidelines is deemed necessary for promoting the health of Korean CHB patients. [...]there can be grey zone in which the features do not correspond to any specific phase. [...]it is often insufficient to determine the clinical stage of infection or to decide antiviral treatment based on a single alanine aminotransferase (ALT) or HBV DNA test (Fig. 1) [1]. The immune-tolerant phase can last for more than three decades in patients infected with HBV genotype C due to late HBeAg seroconversion [8]. [...]many female patients infected with this genotype are in the immune-tolerant phase when they are of childbearing age, which can lead to vertical transmission of |
---|---|
AbstractList | INTRODUCTION Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a threat to public health due to its high morbidity and disease-related mortality. Since the latest version of clinical practice guidelines of CHB in 2018 by the Korean Association for the Study of the Liver (KASL), many studies related to hepatitis B virus (HBV) have been published, raising the need to revise the recommendations reflecting the most up-to-date information on management of CHB. The KASL will continue to update part or all of these guidelines based on publication of new study results. [...]revision of the guidelines is deemed necessary for promoting the health of Korean CHB patients. [...]there can be grey zone in which the features do not correspond to any specific phase. [...]it is often insufficient to determine the clinical stage of infection or to decide antiviral treatment based on a single alanine aminotransferase (ALT) or HBV DNA test (Fig. 1) [1]. The immune-tolerant phase can last for more than three decades in patients infected with HBV genotype C due to late HBeAg seroconversion [8]. [...]many female patients infected with this genotype are in the immune-tolerant phase when they are of childbearing age, which can lead to vertical transmission of KCI Citation Count: 0 |
Author | The Korean Association for the Study of the Liver |
Author_xml | – sequence: 1 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35430783$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002829249$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1kstv1DAQhyNUREvpkSuKxAUOWfx-XJCWCsqKlZCgSNwsx5nsepvEi50g8d_j7LYVrYQvY42_-Xlez4uTIQxQFC8xWlDK0TvXbxcEEbJASLEnxRkhSlZE8Z8nd3dJ1GlxkdIO5SMR4Zo-K04pZxRJRc-Kqy_L7-vSdX7wznblPlo3egflZvINZC-ksg2x7O1gN9DDMJahLd02hsyXW9jb0Y8-lR9eFE9b2yW4uLXnxY9PH68vP1frr1ery-W6chzzsZL5V95irWwjcK05Bi2ZJjn9BstGaSFd03LLLShgHKBWnDFNJYgcVjNBz4u3R90htubGeROsP9hNMDfRLL9dr4zWTDOlM7s6sk2wO7OPvrfxzyHg4AhxY2zM1XZgWoe1EAI7XBOGhLAMWVxb51itgFuZtd4ftfZT3UPjciei7R6IPnwZ_Dbn9NtohKkgLAu8uRWI4dcEaTS9Tw66zg4QpmSI4HmSUsm5xteP0F2Y4pDbaigmnFNG9Vzdq38zuk_lbrYZqI6AiyGlCO09gpGZ18fk9THz-ph5fTJPH_HOj3m-YS7Id_-J-gtt-cYc |
CitedBy_id | crossref_primary_10_1016_j_jhep_2024_08_016 crossref_primary_10_1111_apt_17329 crossref_primary_10_3350_cmh_2024_0163 crossref_primary_10_1177_14703203241294037 crossref_primary_10_1038_s41598_022_11736_1 crossref_primary_10_1007_s12072_023_10528_7 crossref_primary_10_1111_liv_15597 crossref_primary_10_1111_apt_17643 crossref_primary_10_17998_jlc_2023_08_03 crossref_primary_10_3350_cmh_2023_0079 crossref_primary_10_3390_diagnostics14050495 crossref_primary_10_4103_sjg_sjg_279_23 crossref_primary_10_1080_07853890_2024_2428431 crossref_primary_10_1136_gutjnl_2023_330225 crossref_primary_10_3390_diagnostics14010014 crossref_primary_10_1111_liv_16139 crossref_primary_10_1002_jia2_26358 crossref_primary_10_1111_jvh_13988 crossref_primary_10_3350_cmh_2023_0328 crossref_primary_10_3350_cmh_2024_0055 crossref_primary_10_3350_cmh_2024_0451 crossref_primary_10_4166_kjg_2022_096 crossref_primary_10_1016_j_heliyon_2024_e31065 crossref_primary_10_1111_jvh_14036 crossref_primary_10_1155_2024_6635625 crossref_primary_10_3350_cmh_2023_0044 crossref_primary_10_1186_s12885_023_11059_y crossref_primary_10_3390_diagnostics13091537 crossref_primary_10_1186_s12876_023_02846_9 crossref_primary_10_12677_ACM_2023_1351216 crossref_primary_10_1111_1751_2980_13172 crossref_primary_10_1016_j_jhepr_2025_101391 crossref_primary_10_3904_kjm_2024_99_3_140 crossref_primary_10_1002_jmv_70253 crossref_primary_10_18525_cu_2024_9_2_70 crossref_primary_10_1186_s12876_023_02996_w crossref_primary_10_3904_kjim_2023_311 crossref_primary_10_12998_wjcc_v11_i32_7785 crossref_primary_10_3904_kjm_2024_99_5_232 crossref_primary_10_1111_jvh_13956 crossref_primary_10_7326_M24_0384 crossref_primary_10_1111_liv_16032 crossref_primary_10_2147_OTT_S444536 crossref_primary_10_3350_cmh_2024_0149 crossref_primary_10_3350_cmh_2024_0506 crossref_primary_10_1111_jgh_16667 crossref_primary_10_12998_wjcc_v11_i33_8078 crossref_primary_10_3904_kjm_2022_97_6_353 crossref_primary_10_1016_j_jhep_2024_12_029 crossref_primary_10_1111_hiv_13545 crossref_primary_10_3350_cmh_2023_0054 crossref_primary_10_1016_j_jhepr_2024_101089 crossref_primary_10_1111_jgh_16132 crossref_primary_10_1016_j_jhep_2022_08_026 crossref_primary_10_1111_apt_17819 crossref_primary_10_1097_MEG_0000000000002504 crossref_primary_10_1002_jmv_70187 crossref_primary_10_1186_s13027_022_00478_4 crossref_primary_10_3350_cmh_2022_0294 crossref_primary_10_1111_jvh_13926 crossref_primary_10_3389_fonc_2023_1142661 crossref_primary_10_1016_j_jhep_2023_09_011 crossref_primary_10_3348_kjr_2022_0822 crossref_primary_10_1016_j_eclinm_2024_103038 crossref_primary_10_1016_j_eclinm_2024_103039 crossref_primary_10_3390_cancers15112936 crossref_primary_10_1111_apt_17532 crossref_primary_10_17998_jlc_2022_11_07 crossref_primary_10_3350_cmh_2024_0519 crossref_primary_10_1097_MD_0000000000034276 crossref_primary_10_14309_ajg_0000000000002234 |
Cites_doi | 10.1002/hep.27735 10.1111/liv.14606 10.1111/ecc.12799 10.1371/journal.pone.0132426 10.1038/ajg.2014.157 10.1111/liv.12112 10.1136/gutjnl-2021-iddf.79 10.3350/cmh.2020.0115 10.5009/gnl.2012.6.2.241 10.1093/jnci/djp180 10.1002/hep.23905 10.1016/j.jhep.2014.11.031 10.1111/jvh.13511 10.1111/apt.13272 10.1093/infdis/jiaa136 10.3350/cmh.2015.21.3.232 10.1053/j.gastro.2012.02.007 10.3851/imp2097 10.1002/hep.31610 10.1016/j.cgh.2021.06.019 10.1002/hep.510290312 10.1038/ajg.2016.109 10.1002/hep.20110 10.1016/j.jhep.2019.06.028 10.1053/j.gastro.2010.04.048 10.3851/imp2728 10.1016/j.jhep.2008.07.014 10.1016/j.jcv.2013.03.010 10.1136/gutjnl-2014-306977 10.1002/lt.21675 10.1093/ndt/gfn684 10.1111/j.1525-139x.2005.18108.x 10.3109/10428194.2015.1116121 10.1007/s12072-021-10223-5 10.1111/apt.15058 10.3350/cmh.2020.0049 10.1007/s12072-009-9140-3 10.1111/j.1440-1746.2010.06541.x 10.1053/jhep.2003.50220 10.1016/j.ejso.2013.03.020 10.1038/ajg.2013.111 10.1002/jmv.24715 10.1111/j.1349-7006.2011.02170.x 10.1097/tp.0000000000001786 10.1136/gutjnl-2013-305517 10.1002/hep.21724 10.1002/hep.28115 10.1016/s1386-6346(03)00158-x 10.1016/s2468-1253(17)30083-3 10.1016/j.antiviral.2020.104992 10.1111/j.1872-034x.2011.00796.x 10.1097/01.tp.0000163468.80223.74 10.1016/j.jhep.2015.11.035 10.1371/journal.pone.0104480 10.1080/14712598.2016.1177017 10.3350/kjhep.2012.18.1.1 10.1111/j.1365-2893.2008.00989.x 10.1053/j.gastro.2014.10.038 10.1001/jama.2014.15704 10.1128/aac.01734-18 10.1097/md.0000000000010940 10.1111/bcp.13450 10.3390/ijms161226087 10.1002/hep4.1633 10.1016/j.jhep.2018.08.012 10.1111/ctr.12410 10.1016/j.transproceed.2005.06.068 10.1007/s12072-017-9817-y 10.1016/j.cmi.2016.07.021 10.1016/j.jhep.2017.09.018 10.3748/wjg.v20.i24.7675 10.1016/j.jhep.2020.01.007 10.1055/s-2003-37590 10.1056/nejm199504063321401 10.1111/liv.15011 10.1016/j.cgh.2021.06.001 10.1111/jvh.12754 10.1053/j.gastro.2012.10.005 10.1016/j.jhep.2016.05.029 10.14309/ajg.0000000000001497 10.1097/sla.0000000000002727 10.1016/j.cgh.2020.02.044 10.1111/jvh.12840 10.1016/j.jhep.2019.11.003 10.1093/infdis/jix461 10.1111/j.1572-0241.2005.00232.x 10.1016/j.jhep.2017.11.039 10.1016/j.jhep.2020.02.030 10.1002/hep.29213 10.3346/jkms.2015.30.11.1618 10.1111/apt.14613 10.3899/jrheum.081324 10.1111/j.1440-1746.2006.04547.x 10.1111/liv.13450 10.1002/hep.32135 10.3350/cmh.2020.0032 10.1111/jvh.12356 10.3350/cmh.2016.0037 10.1002/hep.26718 10.1002/hep.31850 10.1002/hep.28156 10.1093/cid/ciaa807 10.1111/liv.12154 10.1136/gut.2004.040675 10.1128/aac.01463-20 10.1016/s1470-2045(11)70077-8 10.1111/tid.12065 10.1002/hep.24555 10.1016/j.jhep.2016.09.028 10.1016/j.jhep.2013.09.029 10.1053/j.gastro.2003.09.026 10.1371/journal.pone.0144777 10.1016/j.bpg.2017.04.010 10.1038/nrgastro.2013.216 10.5009/gnl16403 10.1111/apt.14177 10.1016/j.jhep.2008.07.023 10.1111/jvh.12927 10.1056/nejmoa040431 10.1002/jmv.25241 10.1097/00000658-200101000-00020 10.1007/s12072-015-9667-4 10.1016/j.jhep.2021.09.025 10.1371/journal.pone.0044930 10.1111/jvh.13528 10.1007/s13277-013-0709-z 10.1016/j.transproceed.2013.01.093 10.3851/imp1840 10.1007/s12072-021-10239-x 10.1111/apt.12590 10.1016/s2468-1253(19)30346-2 10.1016/j.transproceed.2016.11.010 10.1016/0168-8278(90)90069-4 10.1016/s0168-8278(20)30650-4 10.1002/hep.21024 10.1111/apt.13659 10.1111/j.1478-3231.2012.02770.x 10.4254/wjh.v8.i8.385 10.1200/jco.2009.26.2675 10.1111/liv.13001 10.1053/gast.2002.36026 10.1111/ajt.13187 10.1097/cji.0000000000000358 10.1046/j.1523-1755.2003.00017.x 10.1034/j.1399-3062.2003.00021.x 10.1038/s41467-019-10200-5 10.1002/hep.23323 10.1002/hep4.1708 10.1186/s12957-019-1577-9 10.1002/hep.30474 10.1016/s2468-1253(16)30107-8 10.1182/blood.v99.7.2324 10.1182/blood.2019000017 10.1097/00007890-199810150-00012 10.1200/jco.2008.18.0182 10.1002/hep.28552 10.1111/j.1478-3231.2004.0964.x 10.1111/liv.13489 10.1016/j.jcv.2004.10.006 10.1371/journal.pone.0122041 10.1002/hep.21627 10.1016/0016-5085(95)90401-8 10.3350/cmh.2021.0093 10.1016/s0168-8278(87)80008-9 10.1053/j.gastro.2005.11.016 10.1038/ajg.2017.93 10.1136/gutjnl-2019-320015 10.1093/jac/dku502 10.1002/hep.29318 10.1111/liv.14129 10.1093/cid/ciab302 10.1038/s41591-021-01513-4 10.1002/hep.27382 10.1053/jhep.2001.27834 10.1016/j.cgh.2019.05.057 10.1002/hep.28916 10.1016/s0168-8278(02)00349-5 10.1016/j.cgh.2020.04.089 10.1002/hep.30325 10.14309/ajg.0000000000001219 10.1053/j.gastro.2004.09.014 10.1016/j.clinre.2018.10.020 10.1111/1469-0691.12739 10.1002/hep.28280 10.1111/jvh.12855 10.1016/j.jhepr.2020.100175 10.1111/j.1365-2036.2011.04634.x 10.1111/liv.12882 10.1136/gutjnl-2020-321116 10.1093/annonc/mdh430 10.1016/0016-5085(87)90613-5 10.1007/s12072-007-9020-7 10.1053/jhep.2002.35068 10.1016/s0168-8278(20)30790-x 10.3346/jkms.2005.20.5.816 10.1097/mcg.0000000000000852 10.1053/jhep.2003.50208 10.1016/j.jcv.2012.07.015 10.3350/kjhep.2009.15.2.140 10.1111/ctr.12022 10.1007/s10620-011-1659-1 10.1016/s0140-6736(12)61425-1 10.1002/cncr.29537 10.1016/j.jhep.2018.11.030 10.1002/jgh3.12636 10.3350/cmh.2016.0047 10.1007/s00535-015-1153-1 10.1007/s11096-016-0358-6 10.1016/j.jhep.2004.04.032 10.1136/gutjnl-2011-301430 10.1016/s0168-8278(02)00004-1 10.1128/aac.02400-13 10.1002/hep.23785 10.1016/j.jcv.2013.06.035 10.1111/j.1365-2893.2010.01329.x 10.1002/jmv.10430 10.1016/j.bbmt.2011.04.006 10.1111/apt.15725 10.1016/j.jhep.2022.01.007 10.3390/v9060156 10.1016/j.dld.2017.10.002 10.1053/j.gastro.2020.04.036 10.1002/path.2993 10.1136/gut.2005.065136 10.1002/hep.22742 10.1111/jgh.12472 10.1002/hep.23505 10.1097/md.0000000000004433 10.1002/lt.23628 10.1111/j.1365-2036.2012.04993.x 10.1007/s00262-021-02911-w 10.1093/ndt/gfw455 10.1371/journal.pone.0184550 10.1038/bmt.2015.328 10.1371/journal.pone.0179680 10.1073/pnas.91.9.4077 10.1111/liv.13346 10.3904/kjim.2007.22.2.73 10.1016/j.ejca.2013.07.006 10.1007/s10620-011-1597-y 10.1016/j.jhep.2017.07.033 10.1158/1055-9965.epi-15-0137 10.1016/j.cgh.2018.11.001 10.1053/j.gastro.2016.07.012 10.1097/md.0000000000003671 10.1111/j.1478-3231.2010.02267.x 10.1038/ajg.2016.517 10.1016/0016-5085(91)90599-g 10.1016/s0168-8278(20)30773-x 10.1002/hep.22106 10.1055/s-0041-1723088 10.7326/0003-4819-148-7-200804010-00008 10.1002/hep.26436 10.1002/1096-9071(20000201)63 10.1053/j.gastro.2020.02.058 10.1111/j.1365-2893.2010.01386.x 10.1172/jci115590 10.1158/1078-0432.ccr-21-0002 10.1002/1096-9071(200011)62 10.1002/hep.21612 10.1002/hep.27889 10.1016/j.jhep.2020.01.027 10.1002/jmv.20434 10.1053/j.gastro.2011.06.036 10.3899/jrheum.090436 10.1053/gast.2002.35352 10.3350/kjhep.2011.17.3.199 10.1002/hep.28438 10.1111/j.1399-0012.2011.01409.x 10.1002/jmv.21501 10.3350/cmh.2021.0179 10.1053/gast.2002.33588 10.1136/gut.46.3.420 10.3851/imp2381 10.1002/hep.1840130403 10.1056/nejmoa0802878 10.1007/s10620-014-3486-7 10.1136/gutjnl-2020-321309 10.1111/1756-185x.12154 10.1016/j.jhep.2010.06.043 10.1016/j.jhep.2019.03.034 10.1007/s12072-015-9675-4 10.1016/j.jhep.2016.04.016 10.1002/hep.29082 10.1016/j.jhep.2020.04.008 10.1056/nejmoa066422 10.1038/ncomms12992 10.1056/nejmoa051285 10.1016/s1386-6346(03)00002-0 10.1016/j.cmi.2017.06.023 10.1111/apt.15741 10.1001/2012.jama.11975 10.1053/j.gastro.2018.12.023 10.1111/liv.13314 10.1136/gutjnl-2020-323888 10.1093/infdis/jiab597 10.1016/j.cgh.2007.01.005 10.1111/j.1572-0241.2004.40069.x 10.1038/s41598-019-39043-2 10.1002/hep.24109 10.1002/hep.20956 10.3350/cmh.2022.0012 10.1200/jco.2015.61.3745 10.1046/j.1365-2141.2001.03099.x 10.1111/j.1600-6143.2010.03046.x 10.1097/tp.0000000000001769 10.1038/ng.2295 10.3350/cmh.2017.0068 10.1136/gutjnl-2020-323153 10.1136/gutjnl-2017-314904 10.1053/j.gastro.2017.02.009 10.1093/infdis/jix506 10.1016/j.ejim.2021.02.019 10.1056/nejmoa051287 10.1053/j.gastro.2019.10.050 10.1007/s10620-021-07312-8 10.1016/j.leukres.2016.09.014 10.1016/j.cgh.2021.04.045 10.1002/hep.510240201 10.1056/nejmoa0912696 10.1016/0016-5085(85)90566-9 10.1016/s2468-1253(17)30288-1 10.1053/jhep.2002.33638 10.4254/wjh.v10.i2.337 10.1053/j.gastro.2008.10.089 10.1007/s15010-004-3080-6 10.7326/0003-4819-118-3-199302010-00006 10.1111/j.1600-0609.2004.00376.x 10.1056/nejmoa020681 10.1002/phar.1803 10.1097/mcg.0000000000000675 10.1002/hep.29191 10.7326/0003-4819-137-1-200207020-00006 10.1016/s2468-1253(19)30421-2 10.1002/hep.31026 10.1002/hep.32018 10.14309/ctg.0000000000000290 10.1016/j.jhep.2016.08.009 10.1002/acr.23346 10.1002/hep.21077 10.1111/j.1743-7563.2012.01534.x 10.1016/j.amjmed.2003.12.040 10.1002/hep.29800 10.1016/j.bbmt.2018.02.027 10.1136/gut.2005.070763 10.1002/hep.22898 10.1128/jvi.78.16.8524-8535.2004 10.1038/s41598-018-23343-0 10.1093/cid/ciz860 10.1002/hep.32241 10.1097/00007890-199501270-00014 10.1016/j.jhep.2018.07.018 10.1200/jco.1990.8.6.963 10.3109/00365548.2012.680488 10.1038/sj.thj.6200300 10.1097/cej.0000000000000252 10.1136/gutjnl-2015-309809 10.1046/j.1365-2893.2002.00304.x 10.1038/srep33743 10.1002/hep4.1761 10.1111/jvh.13345 10.1002/jmv.24423 10.1093/cid/ciab007 10.1111/jvh.12258 10.1111/apt.16267 10.1002/hep.27102 10.18632/oncotarget.7832 10.1309/ajcp8qdn7nauxjfj 10.1016/j.ijrobp.2007.04.005 10.1016/j.jhep.2017.10.018 10.1371/journal.pone.0169444 10.1111/j.1478-3231.2011.02749.x 10.1111/jvh.13185 10.1097/md.0000000000006835 10.1016/j.jhep.2015.07.009 10.1200/jco.20.01757 10.1016/j.cgh.2015.05.029 10.1053/j.gastro.2007.08.010 10.1002/jmv.22095 10.1002/hep.29321 10.1002/hep.31289 10.3390/jpm11111108 10.1097/tp.0000000000002173 10.1371/journal.pone.0201316 10.1007/s12032-011-9974-0 10.1128/jvi.01863-06 10.1097/md.0000000000002995 10.1016/j.dld.2022.01.047 10.1186/s12876-017-0735-1 10.1053/j.gastro.2018.11.037 10.3350/cmh.2020.0307 10.1111/apt.14352 10.1016/j.dld.2018.03.032 10.1007/s10620-019-05614-6 10.1111/jvh.13506 10.1002/hep.30973 10.1002/hep.29022 10.1136/gutjnl-2013-306409 10.1002/hep.21783 10.1097/tp.0000000000000234 10.1111/jvh.12643 10.3350/cmh.2020.0216 10.1053/j.gastro.2019.03.044 10.1002/hep.21051 10.1136/gutjnl-2020-323979 10.1111/tri.12370 10.1097/00007890-200201150-00016 10.1097/md.0b013e3182380a76 10.1002/hep.29109 10.1111/jvh.12851 10.14309/ajg.0000000000000605 10.1200/jco.2012.48.5896 10.1016/j.jhep.2014.04.029 10.1053/j.gastro.2014.10.039 10.1016/j.jhep.2020.04.013 10.1111/liv.12805 10.1517/14656560903251710 10.1093/jnci/djn243 10.1002/hep.20435 10.1002/hep.29640 10.1016/j.jhep.2017.06.019 10.1111/jgh.12898 10.1111/apt.14376 10.1016/j.jhep.2009.11.009 10.1111/j.1600-0676.1990.tb00429.x 10.1136/bmjopen-2016-013739 10.1111/liv.13142 10.1016/j.jhep.2016.05.016 10.1111/jgh.15678 10.1016/j.jhep.2018.10.014 10.1016/s1470-2045(10)70167-4 10.1111/liv.13705 10.1016/j.jhep.2014.02.013 10.1016/j.jhep.2009.11.007 10.1200/jco.2011.40.7510 10.1111/apt.15311 10.1002/hep.27723 10.1016/j.jhep.2011.06.016 10.1001/jama.295.1.65 10.1002/hep.23190 10.1002/cncr.24742 10.1016/j.antiviral.2015.06.019 10.1007/s10620-014-3054-1 10.1016/s2468-1253(16)30024-3 10.1111/j.1478-3231.2011.02693.x 10.1002/hep.28266 10.1002/hep.32259 10.1016/j.cgh.2020.12.005 10.3350/cmh.2014.20.4.355 10.1056/nejmoa021812 10.1128/jvi.68.12.8102-8110.1994 10.1200/jco.2004.05.161 10.3350/cmh.2012.18.2.195 10.1007/s40265-020-01464-z 10.1053/j.gastro.2014.01.044 10.1007/s12072-021-10263-x 10.2147/jep.s235550 10.1002/hep.1840120406 10.1053/j.gastro.2015.09.043 10.1053/gast.2003.50053 |
ContentType | Journal Article |
Copyright | 2022. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2022 by The Korean Association for the Study of the Liver 2022 |
Copyright_xml | – notice: 2022. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2022 by The Korean Association for the Study of the Liver 2022 |
CorporateAuthor | The Korean Association for the Study of the Liver (KASL) Korean Association for the Study of the Liver (KASL) |
CorporateAuthor_xml | – name: The Korean Association for the Study of the Liver (KASL) – name: Korean Association for the Study of the Liver (KASL) |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI 7X8 5PM DOA ACYCR |
DOI | 10.3350/cmh.2022.0084 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2287-285X |
EndPage | 331 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9949489 oai_doaj_org_article_fc196661c1b24066a40a1bacc4b8e5a7 PMC9013624 35430783 10_3350_cmh_2022_0084 |
Genre | Guideline General Information |
GroupedDBID | 5-W 7X7 8FI 8FJ 8JR 8XY 9ZL AAYXX ABUWG ACYCR ADBBV AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK EBD EF. EMOBN FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M48 PGMZT PHGZM PHGZT PIMPY RNS RPM SV3 UKHRP ADRAZ CGR CUY CVF ECM EIF IPNFZ NPM RIG 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c515t-70785f198ad61b951e97492008d17d8967cdf5a5ae8e45eeb8544937e685fb463 |
IEDL.DBID | M48 |
ISSN | 2287-2728 2287-285X |
IngestDate | Mon May 19 06:03:45 EDT 2025 Wed Aug 27 01:21:48 EDT 2025 Thu Aug 21 18:08:27 EDT 2025 Thu Sep 04 15:58:11 EDT 2025 Mon Jun 30 14:51:23 EDT 2025 Thu Apr 03 07:03:55 EDT 2025 Tue Jul 01 04:27:43 EDT 2025 Thu Apr 24 23:01:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Treatment Disease management Chronic hepatitis B KASL guidelines Therapeutics |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c515t-70785f198ad61b951e97492008d17d8967cdf5a5ae8e45eeb8544937e685fb463 |
Notes | SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 content type line 23 Clinical Practice Guidelines Committee of KASL for the Management of Chronic Hepatitis B: Jeong Won Jang (Committee chair, The Catholic University of Korea), Jun Yong Park (Yonsei University College of Medicine), Jung Hyun Kwon (The Catholic University of Korea), Su Jong Yu (Seoul National University College of Medicine), Wonseok Kang (Sungkyunkwan University School of Medicine), Young Eun Chon (CHA University College of Medicine), Tae Hyung Kim (Korea University College of Medicine), Jonggi Choi (University of Ulsan College of Medicine), Jihyun An (Hanyang University College of Medicine) Editor: Seung Up Kim, Yonsei University College of Medicine, Korea |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3350/cmh.2022.0084 |
PMID | 35430783 |
PQID | 3125534399 |
PQPubID | 7084873 |
PageCount | 56 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9949489 doaj_primary_oai_doaj_org_article_fc196661c1b24066a40a1bacc4b8e5a7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9013624 proquest_miscellaneous_2652027876 proquest_journals_3125534399 pubmed_primary_35430783 crossref_primary_10_3350_cmh_2022_0084 crossref_citationtrail_10_3350_cmh_2022_0084 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-04-01 2022-04-00 20220401 2022-04 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) – name: Seoul |
PublicationTitle | Clinical and molecular hepatology |
PublicationTitleAlternate | Clin Mol Hepatol |
PublicationYear | 2022 |
Publisher | Korean Association for the Study of the Liver The Korean Association for the Study of the Liver 대한간학회 |
Publisher_xml | – name: Korean Association for the Study of the Liver – name: The Korean Association for the Study of the Liver – name: 대한간학회 |
References | ref57 ref207 ref328 ref449 ref56 ref208 ref329 ref59 ref205 ref326 ref447 ref58 ref206 ref327 ref448 ref53 ref203 ref324 ref445 ref52 ref204 ref446 ref55 ref201 ref322 ref443 ref54 ref202 ref323 ref444 ref209 ref210 ref331 ref452 ref211 ref332 ref453 ref51 ref450 ref50 ref330 ref451 ref46 ref218 ref45 ref219 ref216 ref337 ref458 ref47 ref217 ref338 ref459 ref42 Lee (ref60) 1997 ref214 ref335 ref456 ref41 ref215 ref336 ref457 ref44 ref212 ref333 ref454 ref43 ref213 ref334 ref455 ref49 ref100 ref221 ref342 ref463 ref101 ref222 ref343 ref464 ref40 ref340 ref461 ref220 ref341 ref462 ref460 ref35 ref306 ref427 ref34 ref307 ref428 ref37 ref304 ref425 ref36 ref305 ref426 ref31 ref302 ref423 ref30 ref303 ref424 ref33 ref300 ref421 ref32 ref301 ref422 ref39 ref38 ref308 ref429 ref309 ref430 ref310 ref431 ref24 ref317 ref438 ref23 ref439 ref26 ref315 ref436 ref25 ref316 ref437 ref20 ref313 ref434 ref314 ref435 ref22 ref311 Rashidi-Alavijeh (ref417) 2021 ref432 ref21 ref312 ref433 ref28 ref27 ref319 ref29 ref320 ref441 ref200 ref321 ref442 ref440 ref128 ref249 ref129 ref97 ref126 ref247 ref368 ref96 ref127 ref248 ref369 ref99 ref124 ref245 ref366 ref487 ref98 ref125 ref246 ref367 ref488 Yoshida (ref235) 2021 ref93 ref133 ref254 ref375 ref92 ref134 ref255 ref376 ref95 ref131 ref252 ref373 ref94 ref132 ref253 ref374 ref250 ref371 ref130 ref251 ref372 ref91 ref90 Wang (ref234) 2021 ref370 ref89 ref139 ref86 ref258 ref379 ref85 ref138 ref259 ref88 ref135 ref256 ref377 ref87 ref136 ref257 ref378 Tsai (ref298) 2021 ref82 ref144 ref265 ref386 ref81 ref145 ref266 ref387 ref84 ref142 ref263 ref384 ref83 ref143 ref264 ref385 ref140 ref261 ref382 ref141 ref262 ref383 ref380 Gane (ref225) 2021 ref260 ref381 ref79 ref108 ref229 ref78 ref109 ref106 ref348 ref469 ref107 ref349 ref75 ref104 ref346 ref74 ref105 ref347 ref468 ref102 ref223 ref344 ref465 ref76 ref103 ref224 ref345 ref466 ref71 ref111 ref353 ref474 ref70 ref112 ref233 ref354 ref475 ref73 ref230 ref351 ref472 ref72 ref110 ref231 ref352 ref473 Yuen (ref227) 2021 ref470 ref350 ref68 ref119 ref67 ref238 ref359 ref69 ref118 ref64 ref115 ref236 ref357 ref478 ref63 ref116 ref237 ref358 ref479 ref66 ref113 ref355 ref476 ref65 ref114 ref356 ref477 ref122 ref243 ref364 ref485 ref123 ref244 ref365 ref486 ref62 ref120 ref241 ref362 ref483 ref61 ref121 ref242 ref363 ref484 ref360 ref481 ref361 ref482 ref480 Sulkowski (ref467) 2016 ref168 ref289 Pradelli (ref80) 2013 ref169 ref290 ref170 ref291 ref177 ref178 ref299 ref296 ref297 ref173 ref294 ref174 ref295 ref171 ref292 ref172 ref293 ref179 Yuen (ref240) 2021 ref180 ref181 ref188 ref189 ref186 ref187 ref184 ref185 ref182 ref183 ref148 ref269 Gupta (ref339) 1990 ref149 ref146 ref267 ref388 ref147 ref268 ref389 ref390 Tang (ref137) 2018 ref155 ref276 ref397 ref156 ref277 ref398 ref153 ref274 ref395 ref154 ref275 ref396 ref272 ref393 ref152 ref273 ref394 ref270 ref391 ref150 ref271 ref392 ref159 ref157 ref278 ref399 ref158 ref279 Jeong (ref471) 2005 ref166 ref287 ref167 ref288 ref164 ref285 ref165 ref286 ref162 ref283 ref163 ref284 ref160 ref281 ref161 ref282 Kim (ref280) 2011 Chen (ref77) 2015 Yuen (ref239) 2019 ref2 ref1 ref191 ref192 (ref176) 2016 (ref117) 2020 ref190 ref199 ref197 ref198 ref195 ref196 ref193 ref194 (ref175) 2015 Yuen (ref228) ref8 ref7 ref9 ref4 ref6 ref5 (ref415) 2016 Gwak (ref325) 2008 Yip (ref48) 2021 Yuen (ref226) 2021 Tran (ref3) 2011 Janssen (ref232) 2021 Sun (ref318) 2020 ref13 ref405 ref12 ref406 ref15 ref403 ref14 ref404 ref401 ref402 ref11 ref10 ref400 ref17 ref409 ref16 ref19 ref407 ref18 ref408 (ref151) 2017 ref416 ref414 ref412 ref413 ref410 ref411 ref418 ref419 ref420 |
References_xml | – ident: ref149 doi: 10.1002/hep.27735 – ident: ref124 doi: 10.1111/liv.14606 – ident: ref375 doi: 10.1111/ecc.12799 – ident: ref183 doi: 10.1371/journal.pone.0132426 – ident: ref86 doi: 10.1038/ajg.2014.157 – ident: ref300 doi: 10.1111/liv.12112 – ident: ref334 doi: 10.1136/gutjnl-2021-iddf.79 – ident: ref131 doi: 10.3350/cmh.2020.0115 – ident: ref455 doi: 10.5009/gnl.2012.6.2.241 – ident: ref61 doi: 10.1093/jnci/djp180 – ident: ref111 doi: 10.1002/hep.23905 – ident: ref42 doi: 10.1016/j.jhep.2014.11.031 – ident: ref52 doi: 10.1111/jvh.13511 – ident: ref109 doi: 10.1111/apt.13272 – start-page: 18 volume-title: KASL clinical practice guidelines: management of chronic hepatitis B year: 2016 ident: ref176 – ident: ref279 doi: 10.1093/infdis/jiaa136 – ident: ref187 doi: 10.3350/cmh.2015.21.3.232 – ident: ref107 doi: 10.1053/j.gastro.2012.02.007 – ident: ref438 doi: 10.3851/imp2097 – ident: ref47 doi: 10.1002/hep.31610 – ident: ref317 doi: 10.1016/j.cgh.2021.06.019 – ident: ref58 doi: 10.1002/hep.510290312 – ident: ref272 doi: 10.1038/ajg.2016.109 – ident: ref340 doi: 10.1002/hep.20110 – ident: ref233 doi: 10.1016/j.jhep.2019.06.028 – ident: ref40 doi: 10.1053/j.gastro.2010.04.048 – ident: ref476 doi: 10.3851/imp2728 – ident: ref31 doi: 10.1016/j.jhep.2008.07.014 – ident: ref360 doi: 10.1016/j.jcv.2013.03.010 – ident: ref63 doi: 10.1136/gutjnl-2014-306977 – ident: ref433 doi: 10.1002/lt.21675 – ident: ref328 doi: 10.1093/ndt/gfn684 – ident: ref329 doi: 10.1111/j.1525-139x.2005.18108.x – ident: ref392 doi: 10.3109/10428194.2015.1116121 – ident: ref243 doi: 10.1007/s12072-021-10223-5 – ident: ref276 doi: 10.1111/apt.15058 – ident: ref251 doi: 10.3350/cmh.2020.0049 – ident: ref263 doi: 10.1007/s12072-009-9140-3 – ident: ref103 doi: 10.1111/j.1440-1746.2010.06541.x – ident: ref358 doi: 10.1053/jhep.2003.50220 – ident: ref285 doi: 10.1016/j.ejso.2013.03.020 – ident: ref427 doi: 10.1038/ajg.2013.111 – start-page: 343 volume-title: Natural history of chronic hepatitis type B throughout long-term follow-up year: 1997 ident: ref60 – ident: ref249 doi: 10.1002/jmv.24715 – ident: ref64 doi: 10.1111/j.1349-7006.2011.02170.x – ident: ref423 doi: 10.1097/tp.0000000000001786 – ident: ref46 doi: 10.1136/gutjnl-2013-305517 – ident: ref2 doi: 10.1002/hep.21724 – ident: ref87 doi: 10.1002/hep.28115 – ident: ref307 doi: 10.1016/s1386-6346(03)00158-x – ident: ref196 doi: 10.1016/s2468-1253(17)30083-3 – ident: ref250 doi: 10.1016/j.antiviral.2020.104992 – ident: ref301 doi: 10.1111/j.1872-034x.2011.00796.x – start-page: 62A volume-title: A phase IIa trial of subcutaneously administered PD-L1 antibody ASC22 (envafolimab) in patients with chronic hepatitis B year: 2021 ident: ref234 – ident: ref447 doi: 10.1097/01.tp.0000163468.80223.74 – ident: ref88 doi: 10.1016/j.jhep.2015.11.035 – ident: ref428 doi: 10.1371/journal.pone.0104480 – ident: ref389 doi: 10.1080/14712598.2016.1177017 – ident: ref197 doi: 10.3350/kjhep.2012.18.1.1 – ident: ref150 doi: 10.1111/j.1365-2893.2008.00989.x – ident: ref353 doi: 10.1053/j.gastro.2014.10.038 – ident: ref398 doi: 10.1001/jama.2014.15704 – ident: ref211 doi: 10.1128/aac.01734-18 – ident: ref308 doi: 10.1097/md.0000000000010940 – ident: ref464 doi: 10.1111/bcp.13450 – ident: ref180 doi: 10.3390/ijms161226087 – ident: ref230 doi: 10.1002/hep4.1633 – ident: ref220 doi: 10.1016/j.jhep.2018.08.012 – ident: ref437 doi: 10.1111/ctr.12410 – ident: ref440 doi: 10.1016/j.transproceed.2005.06.068 – ident: ref362 doi: 10.1007/s12072-017-9817-y – ident: ref391 doi: 10.1016/j.cmi.2016.07.021 – ident: ref281 doi: 10.1016/j.jhep.2017.09.018 – ident: ref352 doi: 10.3748/wjg.v20.i24.7675 – ident: ref94 doi: 10.1016/j.jhep.2020.01.007 – ident: ref22 doi: 10.1055/s-2003-37590 – ident: ref350 doi: 10.1056/nejm199504063321401 – ident: ref84 doi: 10.1111/liv.15011 – ident: ref96 doi: 10.1016/j.cgh.2021.06.001 – ident: ref462 doi: 10.1111/jvh.12754 – ident: ref81 doi: 10.1053/j.gastro.2012.10.005 – ident: ref120 doi: 10.1016/j.jhep.2016.05.029 – ident: ref205 doi: 10.14309/ajg.0000000000001497 – ident: ref293 doi: 10.1097/sla.0000000000002727 – ident: ref135 doi: 10.1016/j.cgh.2020.02.044 – ident: ref466 doi: 10.1111/jvh.12840 – ident: ref37 doi: 10.1016/j.jhep.2019.11.003 – ident: ref257 doi: 10.1093/infdis/jix461 – ident: ref303 doi: 10.1111/j.1572-0241.2005.00232.x – ident: ref330 doi: 10.1016/j.jhep.2017.11.039 – ident: ref472 doi: 10.1016/j.jhep.2020.02.030 – ident: ref195 doi: 10.1002/hep.29213 – ident: ref200 doi: 10.3346/jkms.2015.30.11.1618 – ident: ref53 doi: 10.1111/apt.14613 – ident: ref378 doi: 10.3899/jrheum.081324 – ident: ref457 doi: 10.1111/j.1440-1746.2006.04547.x – ident: ref89 doi: 10.1111/liv.13450 – ident: ref134 doi: 10.1002/hep.32135 – ident: ref118 doi: 10.3350/cmh.2020.0032 – ident: ref289 doi: 10.1111/jvh.12356 – ident: ref322 doi: 10.3350/cmh.2016.0037 – ident: ref363 doi: 10.1002/hep.26718 – ident: ref126 doi: 10.1002/hep.31850 – ident: ref1 doi: 10.1002/hep.28156 – ident: ref238 doi: 10.1093/cid/ciaa807 – ident: ref370 doi: 10.1111/liv.12154 – ident: ref379 doi: 10.1136/gut.2004.040675 – ident: ref212 doi: 10.1128/aac.01463-20 – ident: ref85 doi: 10.1016/s1470-2045(11)70077-8 – ident: ref453 doi: 10.1111/tid.12065 – ident: ref254 doi: 10.1002/hep.24555 – ident: ref121 doi: 10.1016/j.jhep.2016.09.028 – ident: ref488 doi: 10.1016/j.jhep.2013.09.029 – ident: ref387 doi: 10.1053/j.gastro.2003.09.026 – ident: ref192 doi: 10.1371/journal.pone.0144777 – ident: ref102 doi: 10.1016/j.bpg.2017.04.010 – start-page: 562 volume-title: Spontaneous reactivation in chronic hepatitis B: patterns and natural history year: 1990 ident: ref339 – ident: ref344 doi: 10.1038/nrgastro.2013.216 – ident: ref148 doi: 10.5009/gnl16403 – ident: ref465 doi: 10.1111/apt.14177 – ident: ref56 doi: 10.1016/j.jhep.2008.07.023 – ident: ref204 doi: 10.1111/jvh.12927 – start-page: S757 volume-title: Safety and efficacy of oral TLR8 agonist, selgantolimod, in viremic adult patients with chronic hepatitis B year: 2021 ident: ref232 – ident: ref253 doi: 10.1056/nejmoa040431 – ident: ref400 doi: 10.1002/jmv.25241 – ident: ref284 doi: 10.1097/00000658-200101000-00020 – ident: ref191 doi: 10.1007/s12072-015-9667-4 – ident: ref98 doi: 10.1016/j.jhep.2021.09.025 – start-page: 1202 volume-title: No evidence of reactivation of hepatitis B virus among patients treated with ledipasvir-sofosbuvir for hepatitis C virus infection year: 2016 ident: ref467 – ident: ref140 doi: 10.1371/journal.pone.0044930 – ident: ref275 doi: 10.1111/jvh.13528 – ident: ref403 doi: 10.1007/s13277-013-0709-z – ident: ref451 doi: 10.1016/j.transproceed.2013.01.093 – start-page: 892 volume-title: Japan society of hepatology guidelines for the management of hepatitis B virus infection: 2019 update year: 2020 ident: ref117 – ident: ref311 doi: 10.3851/imp1840 – ident: ref413 doi: 10.1007/s12072-021-10239-x – ident: ref164 doi: 10.1111/apt.12590 – ident: ref214 doi: 10.1016/s2468-1253(19)30346-2 – ident: ref429 doi: 10.1016/j.transproceed.2016.11.010 – ident: ref12 doi: 10.1016/0168-8278(90)90069-4 – ident: ref231 doi: 10.1016/s0168-8278(20)30650-4 – ident: ref302 doi: 10.1002/hep.21024 – ident: ref321 doi: 10.1111/apt.13659 – ident: ref420 doi: 10.1111/j.1478-3231.2012.02770.x – ident: ref345 doi: 10.4254/wjh.v8.i8.385 – ident: ref487 doi: 10.1200/jco.2009.26.2675 – ident: ref129 doi: 10.1111/liv.13001 – ident: ref23 doi: 10.1053/gast.2002.36026 – ident: ref434 doi: 10.1111/ajt.13187 – ident: ref385 doi: 10.1097/cji.0000000000000358 – ident: ref327 doi: 10.1046/j.1523-1755.2003.00017.x – ident: ref445 doi: 10.1034/j.1399-3062.2003.00021.x – ident: ref218 doi: 10.1038/s41467-019-10200-5 – ident: ref267 doi: 10.1002/hep.23323 – ident: ref244 doi: 10.1002/hep4.1708 – ident: ref288 doi: 10.1186/s12957-019-1577-9 – ident: ref270 doi: 10.1002/hep.30474 – ident: ref331 doi: 10.1016/s2468-1253(16)30107-8 – ident: ref402 doi: 10.1182/blood.v99.7.2324 – ident: ref386 doi: 10.1182/blood.2019000017 – ident: ref446 doi: 10.1097/00007890-199810150-00012 – ident: ref359 doi: 10.1200/jco.2008.18.0182 – ident: ref105 doi: 10.1002/hep.28552 – ident: ref373 doi: 10.1111/j.1478-3231.2004.0964.x – ident: ref194 doi: 10.1111/liv.13489 – ident: ref448 doi: 10.1016/j.jcv.2004.10.006 – ident: ref312 doi: 10.1371/journal.pone.0122041 – ident: ref32 doi: 10.1002/hep.21627 – ident: ref209 doi: 10.1016/0016-5085(95)90401-8 – ident: ref219 doi: 10.3350/cmh.2021.0093 – ident: ref34 doi: 10.1016/s0168-8278(87)80008-9 – ident: ref70 doi: 10.1053/j.gastro.2005.11.016 – ident: ref260 doi: 10.1038/ajg.2017.93 – ident: ref282 doi: 10.1136/gutjnl-2019-320015 – ident: ref323 doi: 10.1093/jac/dku502 – ident: ref76 doi: 10.1002/hep.29318 – ident: ref92 doi: 10.1111/liv.14129 – ident: ref371 doi: 10.1093/cid/ciab302 – ident: ref224 doi: 10.1038/s41591-021-01513-4 – ident: ref139 doi: 10.1002/hep.27382 – ident: ref33 doi: 10.1053/jhep.2001.27834 – ident: ref416 doi: 10.1016/j.cgh.2019.05.057 – ident: ref201 doi: 10.1002/hep.28916 – ident: ref30 doi: 10.1016/s0168-8278(02)00349-5 – ident: ref381 doi: 10.1016/j.cgh.2020.04.089 – start-page: e462 volume-title: Cancer risk in HBV patients with statin and metformin use: a population-based cohort study year: 2015 ident: ref77 – ident: ref242 doi: 10.1002/hep.30325 – ident: ref97 doi: 10.14309/ajg.0000000000001219 – ident: ref69 doi: 10.1053/j.gastro.2004.09.014 – ident: ref116 doi: 10.1016/j.clinre.2018.10.020 – ident: ref43 doi: 10.1111/1469-0691.12739 – ident: ref138 doi: 10.1002/hep.28280 – ident: ref296 doi: 10.1111/jvh.12855 – start-page: 64A volume-title: Long term HBsAg reduction by a nasal administrative therapeutic vaccine containing HBsAg and HBcAg mixed with mucoadhesive CVP (CVP-NASVAC) in patients with chronic HBV infection: the results of 30 months follow up year: 2021 ident: ref235 – start-page: 1390A volume-title: Efficacy and safety of the siRNA JNJ-3989 and/or the capsid assembly modulator (CAM) JNJ-6379 for the treatment of chronic hepatitis B virus infection (CHB): results from the phase 2B REEF-1 study year: 2021 ident: ref240 – ident: ref99 doi: 10.1016/j.jhepr.2020.100175 – ident: ref295 doi: 10.1111/j.1365-2036.2011.04634.x – ident: ref409 doi: 10.1111/liv.12882 – ident: ref122 doi: 10.1136/gutjnl-2020-321116 – ident: ref304 doi: 10.1093/annonc/mdh430 – ident: ref17 doi: 10.1016/0016-5085(87)90613-5 – ident: ref286 doi: 10.1007/s12072-007-9020-7 – ident: ref367 doi: 10.1053/jhep.2002.35068 – ident: ref216 doi: 10.1016/s0168-8278(20)30790-x – ident: ref100 doi: 10.3346/jkms.2005.20.5.816 – ident: ref155 doi: 10.1097/mcg.0000000000000852 – ident: ref258 doi: 10.1053/jhep.2003.50208 – ident: ref449 doi: 10.1016/j.jcv.2012.07.015 – ident: ref101 doi: 10.3350/kjhep.2009.15.2.140 – ident: ref425 doi: 10.1111/ctr.12022 – ident: ref141 doi: 10.1007/s10620-011-1659-1 – ident: ref198 doi: 10.1016/s0140-6736(12)61425-1 – ident: ref262 doi: 10.1002/cncr.29537 – ident: ref114 doi: 10.1016/j.jhep.2018.11.030 – ident: ref401 doi: 10.1002/jgh3.12636 – ident: ref110 doi: 10.3350/cmh.2016.0047 – ident: ref247 doi: 10.1007/s00535-015-1153-1 – ident: ref399 doi: 10.1007/s11096-016-0358-6 – ident: ref181 doi: 10.1016/j.jhep.2004.04.032 – ident: ref255 doi: 10.1136/gutjnl-2011-301430 – ident: ref19 doi: 10.1016/s0168-8278(02)00004-1 – ident: ref186 doi: 10.1128/aac.02400-13 – ident: ref199 doi: 10.1002/hep.23785 – ident: ref418 doi: 10.1016/j.jcv.2013.06.035 – ident: ref473 doi: 10.1111/j.1365-2893.2010.01329.x – ident: ref351 doi: 10.1002/jmv.10430 – ident: ref408 doi: 10.1016/j.bbmt.2011.04.006 – ident: ref152 doi: 10.1111/apt.15725 – ident: ref278 doi: 10.1016/j.jhep.2022.01.007 – ident: ref127 doi: 10.3390/v9060156 – ident: ref188 doi: 10.1016/j.dld.2017.10.002 – ident: ref215 doi: 10.1053/j.gastro.2020.04.036 – ident: ref221 doi: 10.1002/path.2993 – ident: ref166 doi: 10.1136/gut.2005.065136 – ident: ref174 doi: 10.1002/hep.22742 – ident: ref287 doi: 10.1111/jgh.12472 – ident: ref161 doi: 10.1002/hep.23505 – ident: ref55 doi: 10.1097/md.0000000000004433 – ident: ref419 doi: 10.1002/lt.23628 – ident: ref479 doi: 10.1111/j.1365-2036.2012.04993.x – ident: ref319 doi: 10.1007/s00262-021-02911-w – ident: ref452 doi: 10.1093/ndt/gfw455 – ident: ref366 doi: 10.1371/journal.pone.0184550 – ident: ref405 doi: 10.1038/bmt.2015.328 – ident: ref374 doi: 10.1371/journal.pone.0179680 – ident: ref26 doi: 10.1073/pnas.91.9.4077 – ident: ref115 doi: 10.1111/liv.13346 – ident: ref41 doi: 10.3904/kjim.2007.22.2.73 – ident: ref361 doi: 10.1016/j.ejca.2013.07.006 – ident: ref182 doi: 10.1007/s10620-011-1597-y – ident: ref93 doi: 10.1016/j.jhep.2017.07.033 – ident: ref73 doi: 10.1158/1055-9965.epi-15-0137 – ident: ref333 doi: 10.1016/j.cgh.2018.11.001 – ident: ref6 doi: 10.1053/j.gastro.2016.07.012 – ident: ref435 doi: 10.1097/md.0000000000003671 – ident: ref29 doi: 10.1111/j.1478-3231.2010.02267.x – ident: ref160 doi: 10.1038/ajg.2016.517 – start-page: 337 volume-title: Baseline HBV loads do not affect the prognosis of patients with hepatocellular carcinoma receiving anti-programmed cell death-1 immunotherapy year: 2020 ident: ref318 – start-page: 1402A volume-title: Low HBsAg levels maintained following cessation of the GalNac-siRNA, AB-729, in chronic hepatitis B subjects on nucleos(t)ide analogue therapy year: 2021 ident: ref226 – ident: ref346 doi: 10.1016/0016-5085(91)90599-g – ident: ref217 doi: 10.1016/s0168-8278(20)30773-x – ident: ref356 doi: 10.1002/hep.22106 – ident: ref241 doi: 10.1055/s-0041-1723088 – ident: ref348 doi: 10.7326/0003-4819-148-7-200804010-00008 – ident: ref108 doi: 10.1002/hep.26436 – ident: ref324 doi: 10.1002/1096-9071(20000201)63 – ident: ref229 doi: 10.1053/j.gastro.2020.02.058 – ident: ref397 doi: 10.1111/j.1365-2893.2010.01386.x – ident: ref10 doi: 10.1172/jci115590 – ident: ref136 doi: 10.1158/1078-0432.ccr-21-0002 – start-page: 43 volume-title: The prevalence and clinical characteristics of hepatitis-delta infection in Korea year: 2005 ident: ref471 – ident: ref347 doi: 10.1002/1096-9071(200011)62 – ident: ref39 doi: 10.1002/hep.21612 – ident: ref202 doi: 10.1002/hep.27889 – ident: ref461 doi: 10.1016/j.jhep.2020.01.027 – ident: ref20 doi: 10.1002/jmv.20434 – ident: ref165 doi: 10.1053/j.gastro.2011.06.036 – volume-title: HBV RNAi inhibitor RG6346 in phase 1b-2a trial was safe, welltolerated, and resulted in substantial and durable reductions in serum HBsAg levels ident: ref228 – ident: ref380 doi: 10.3899/jrheum.090436 – ident: ref208 doi: 10.1053/gast.2002.35352 – start-page: 1802 volume-title: Chronic hepatitis B infection: a review year: 2018 ident: ref137 – ident: ref454 doi: 10.3350/kjhep.2011.17.3.199 – ident: ref265 doi: 10.1002/hep.28438 – ident: ref432 doi: 10.1111/j.1399-0012.2011.01409.x – ident: ref65 doi: 10.1002/jmv.21501 – ident: ref261 doi: 10.3350/cmh.2021.0179 – start-page: 237 volume-title: EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis year: 2015 ident: ref175 – ident: ref8 doi: 10.1053/gast.2002.33588 – ident: ref474 doi: 10.1136/gut.46.3.420 – ident: ref480 doi: 10.3851/imp2381 – ident: ref35 doi: 10.1002/hep.1840130403 – ident: ref170 doi: 10.1056/nejmoa0802878 – ident: ref320 doi: 10.1007/s10620-014-3486-7 – ident: ref157 doi: 10.1136/gutjnl-2020-321309 – ident: ref382 doi: 10.1111/1756-185x.12154 – ident: ref185 doi: 10.1016/j.jhep.2010.06.043 – ident: ref38 doi: 10.1016/j.jhep.2019.03.034 – ident: ref252 doi: 10.1007/s12072-015-9675-4 – ident: ref481 doi: 10.1016/j.jhep.2016.04.016 – ident: ref394 doi: 10.1002/hep.29082 – ident: ref469 doi: 10.1016/j.jhep.2020.04.008 – ident: ref171 doi: 10.1056/nejmoa066422 – ident: ref132 doi: 10.1038/ncomms12992 – ident: ref168 doi: 10.1056/nejmoa051285 – ident: ref306 doi: 10.1016/s1386-6346(03)00002-0 – ident: ref368 doi: 10.1016/j.cmi.2017.06.023 – ident: ref5 doi: 10.1111/apt.15741 – ident: ref291 doi: 10.1001/2012.jama.11975 – ident: ref213 doi: 10.1053/j.gastro.2018.12.023 – ident: ref268 doi: 10.1111/liv.13314 – start-page: 163 volume-title: Tenofovir is superior to entecavir on recurrence in hepatitis B virus-related hepatocellular carcinoma after curative resection year: 2021 ident: ref298 – ident: ref468 doi: 10.1136/gutjnl-2020-323888 – ident: ref125 doi: 10.1093/infdis/jiab597 – ident: ref143 doi: 10.1016/j.cgh.2007.01.005 – ident: ref305 doi: 10.1111/j.1572-0241.2004.40069.x – ident: ref146 doi: 10.1038/s41598-019-39043-2 – ident: ref184 doi: 10.1002/hep.24109 – ident: ref16 doi: 10.1002/hep.20956 – start-page: 321 volume-title: Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue-induced hepatitis B surface antigen loss year: 2021 ident: ref48 – ident: ref223 doi: 10.3350/cmh.2022.0012 – ident: ref411 doi: 10.1200/jco.2015.61.3745 – ident: ref396 doi: 10.1046/j.1365-2141.2001.03099.x – ident: ref421 doi: 10.1111/j.1600-6143.2010.03046.x – ident: ref444 doi: 10.1097/tp.0000000000001769 – ident: ref133 doi: 10.1038/ng.2295 – ident: ref145 doi: 10.3350/cmh.2017.0068 – ident: ref130 doi: 10.1136/gutjnl-2020-323153 – ident: ref7 doi: 10.1136/gutjnl-2017-314904 – ident: ref316 doi: 10.1053/j.gastro.2017.02.009 – ident: ref156 doi: 10.1093/infdis/jix506 – ident: ref299 doi: 10.1016/j.ejim.2021.02.019 – ident: ref169 doi: 10.1056/nejmoa051287 – ident: ref245 doi: 10.1053/j.gastro.2019.10.050 – ident: ref290 doi: 10.1007/s10620-021-07312-8 – ident: ref393 doi: 10.1016/j.leukres.2016.09.014 – ident: ref336 doi: 10.1016/j.cgh.2021.04.045 – ident: ref142 doi: 10.1002/hep.510240201 – ident: ref475 doi: 10.1056/nejmoa0912696 – ident: ref18 doi: 10.1016/0016-5085(85)90566-9 – ident: ref485 doi: 10.1016/s2468-1253(17)30288-1 – ident: ref14 doi: 10.1053/jhep.2002.33638 – ident: ref436 doi: 10.4254/wjh.v10.i2.337 – ident: ref178 doi: 10.1053/j.gastro.2008.10.089 – ident: ref456 doi: 10.1007/s15010-004-3080-6 – ident: ref21 doi: 10.7326/0003-4819-118-3-199302010-00006 – ident: ref355 doi: 10.1111/j.1600-0609.2004.00376.x – ident: ref173 doi: 10.1056/nejmoa020681 – ident: ref463 doi: 10.1002/phar.1803 – ident: ref179 doi: 10.1097/mcg.0000000000000675 – ident: ref426 doi: 10.1002/hep.29191 – ident: ref162 doi: 10.7326/0003-4819-137-1-200207020-00006 – ident: ref335 doi: 10.1016/s2468-1253(19)30421-2 – ident: ref119 doi: 10.1002/hep.31026 – ident: ref123 doi: 10.1002/hep.32018 – ident: ref49 doi: 10.14309/ctg.0000000000000290 – ident: ref269 doi: 10.1016/j.jhep.2016.08.009 – start-page: 63A volume-title: Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection year: 2021 ident: ref227 – ident: ref384 doi: 10.1002/acr.23346 – ident: ref15 doi: 10.1002/hep.21077 – ident: ref313 doi: 10.1111/j.1743-7563.2012.01534.x – ident: ref4 doi: 10.1016/j.amjmed.2003.12.040 – ident: ref144 doi: 10.1002/hep.29800 – ident: ref406 doi: 10.1016/j.bbmt.2018.02.027 – ident: ref390 doi: 10.1136/gut.2005.070763 – ident: ref13 doi: 10.1002/hep.22898 – ident: ref28 doi: 10.1128/jvi.78.16.8524-8535.2004 – ident: ref75 doi: 10.1038/s41598-018-23343-0 – ident: ref203 doi: 10.1093/cid/ciz860 – ident: ref283 doi: 10.1002/hep.32241 – ident: ref441 doi: 10.1097/00007890-199501270-00014 – ident: ref91 doi: 10.1016/j.jhep.2018.07.018 – ident: ref349 doi: 10.1200/jco.1990.8.6.963 – ident: ref450 doi: 10.3109/00365548.2012.680488 – ident: ref376 doi: 10.1038/sj.thj.6200300 – ident: ref71 doi: 10.1097/cej.0000000000000252 – ident: ref128 doi: 10.1136/gutjnl-2015-309809 – ident: ref25 doi: 10.1046/j.1365-2893.2002.00304.x – ident: ref74 doi: 10.1038/srep33743 – ident: ref266 doi: 10.1002/hep4.1761 – ident: ref256 doi: 10.1111/jvh.13345 – ident: ref395 doi: 10.1002/jmv.24423 – ident: ref248 doi: 10.1093/cid/ciab007 – ident: ref190 doi: 10.1111/jvh.12258 – ident: ref90 doi: 10.1111/apt.16267 – ident: ref478 doi: 10.1002/hep.27102 – ident: ref82 doi: 10.18632/oncotarget.7832 – ident: ref112 doi: 10.1309/ajcp8qdn7nauxjfj – ident: ref309 doi: 10.1016/j.ijrobp.2007.04.005 – ident: ref79 doi: 10.1016/j.jhep.2017.10.018 – start-page: 370 volume-title: EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection year: 2017 ident: ref151 – ident: ref264 doi: 10.1371/journal.pone.0169444 – ident: ref167 doi: 10.1111/j.1478-3231.2011.02749.x – start-page: e13522 volume-title: Safety and efficacy of tenofovir alafenamide in liver transplant recipients: a single center experience year: 2021 ident: ref417 – ident: ref193 doi: 10.1111/jvh.13185 – ident: ref67 doi: 10.1097/md.0000000000006835 – ident: ref78 doi: 10.1016/j.jhep.2015.07.009 – ident: ref412 doi: 10.1200/jco.20.01757 – ident: ref477 doi: 10.1016/j.cgh.2015.05.029 – ident: ref9 doi: 10.1053/j.gastro.2007.08.010 – ident: ref470 doi: 10.1002/jmv.22095 – ident: ref159 doi: 10.1002/hep.29321 – ident: ref297 doi: 10.1002/hep.31289 – ident: ref410 doi: 10.3390/jpm11111108 – ident: ref443 doi: 10.1097/tp.0000000000002173 – ident: ref310 doi: 10.1371/journal.pone.0201316 – ident: ref364 doi: 10.1007/s12032-011-9974-0 – ident: ref372 doi: 10.1128/jvi.01863-06 – ident: ref458 doi: 10.1097/md.0000000000002995 – ident: ref482 doi: 10.1016/j.dld.2022.01.047 – ident: ref369 doi: 10.1186/s12876-017-0735-1 – ident: ref104 doi: 10.1053/j.gastro.2018.11.037 – ident: ref338 doi: 10.3350/cmh.2020.0307 – ident: ref459 doi: 10.1111/apt.14352 – ident: ref424 doi: 10.1016/j.dld.2018.03.032 – ident: ref414 doi: 10.1007/s10620-019-05614-6 – ident: ref95 doi: 10.1111/jvh.13506 – ident: ref83 doi: 10.1002/hep.30973 – ident: ref407 doi: 10.1002/hep.29022 – ident: ref158 doi: 10.1136/gutjnl-2013-306409 – ident: ref388 doi: 10.1002/hep.21783 – ident: ref439 doi: 10.1097/tp.0000000000000234 – start-page: 1489A volume-title: First clinical experience with RNA interference-based triple combination therapy in chronic hepatitis B: JNJ-3989, JNJ-6379 and a nucleos(t)ide analogue year: 2019 ident: ref239 – ident: ref50 doi: 10.1111/jvh.12643 – ident: ref147 doi: 10.3350/cmh.2020.0216 – ident: ref237 doi: 10.1053/j.gastro.2019.03.044 – ident: ref343 doi: 10.1002/hep.21051 – start-page: 511 volume-title: Immune tolerant hepatitis B: a clinical dilemma year: 2011 ident: ref3 – ident: ref246 doi: 10.1136/gutjnl-2020-323979 – ident: ref422 doi: 10.1111/tri.12370 – ident: ref442 doi: 10.1097/00007890-200201150-00016 – ident: ref383 doi: 10.1097/md.0b013e3182380a76 – start-page: 433 volume-title: EASL clinical practice guidelines: liver transplantation year: 2016 ident: ref415 – ident: ref460 doi: 10.1002/hep.29109 – ident: ref274 doi: 10.1111/jvh.12851 – ident: ref337 doi: 10.14309/ajg.0000000000000605 – ident: ref292 doi: 10.1200/jco.2012.48.5896 – ident: ref271 doi: 10.1016/j.jhep.2014.04.029 – ident: ref354 doi: 10.1053/j.gastro.2014.10.039 – ident: ref36 doi: 10.1016/j.jhep.2020.04.013 – ident: ref314 doi: 10.1111/liv.12805 – ident: ref404 doi: 10.1517/14656560903251710 – ident: ref62 doi: 10.1093/jnci/djn243 – ident: ref326 doi: 10.1002/hep.20435 – ident: ref273 doi: 10.1002/hep.29640 – ident: ref44 doi: 10.1016/j.jhep.2017.06.019 – ident: ref315 doi: 10.1111/jgh.12898 – ident: ref113 doi: 10.1111/apt.14376 – ident: ref431 doi: 10.1016/j.jhep.2009.11.009 – ident: ref341 doi: 10.1111/j.1600-0676.1990.tb00429.x – start-page: S289 volume-title: Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors year: 2021 ident: ref225 – ident: ref72 doi: 10.1136/bmjopen-2016-013739 – ident: ref59 doi: 10.1111/liv.13142 – ident: ref236 doi: 10.1016/j.jhep.2016.05.016 – ident: ref259 doi: 10.1111/jgh.15678 – ident: ref45 doi: 10.1016/j.jhep.2018.10.014 – ident: ref357 doi: 10.1016/s1470-2045(10)70167-4 – ident: ref153 doi: 10.1111/liv.13705 – ident: ref189 doi: 10.1016/j.jhep.2014.02.013 – ident: ref207 doi: 10.1016/j.jhep.2009.11.007 – ident: ref365 doi: 10.1200/jco.2011.40.7510 – ident: ref54 doi: 10.1111/apt.15311 – ident: ref206 doi: 10.1002/hep.27723 – ident: ref430 doi: 10.1016/j.jhep.2011.06.016 – ident: ref68 doi: 10.1001/jama.295.1.65 – ident: ref24 doi: 10.1002/hep.23190 – ident: ref342 doi: 10.1002/cncr.24742 – ident: ref222 doi: 10.1016/j.antiviral.2015.06.019 – ident: ref51 doi: 10.1007/s10620-014-3054-1 – ident: ref332 doi: 10.1016/s2468-1253(16)30024-3 – start-page: 1721 volume-title: Occult hepatitis B virus infection in chronic hemodialysis patients in Korea year: 2008 ident: ref325 – ident: ref106 doi: 10.1111/j.1478-3231.2011.02693.x – ident: ref294 doi: 10.1002/hep.28266 – ident: ref484 doi: 10.1002/hep.32259 – ident: ref277 doi: 10.1016/j.cgh.2020.12.005 – ident: ref177 doi: 10.3350/cmh.2014.20.4.355 – ident: ref172 doi: 10.1056/nejmoa021812 – ident: ref27 doi: 10.1128/jvi.68.12.8102-8110.1994 – ident: ref377 doi: 10.1200/jco.2004.05.161 – ident: ref163 doi: 10.3350/cmh.2012.18.2.195 – ident: ref483 doi: 10.1007/s40265-020-01464-z – start-page: 64 volume-title: HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma year: 2011 ident: ref280 – ident: ref154 doi: 10.1053/j.gastro.2014.01.044 – ident: ref57 doi: 10.1007/s12072-021-10263-x – ident: ref486 doi: 10.2147/jep.s235550 – ident: ref11 doi: 10.1002/hep.1840120406 – ident: ref210 doi: 10.1053/j.gastro.2015.09.043 – start-page: 229 volume-title: Statins and primary liver cancer: a meta-analysis of observational studies year: 2013 ident: ref80 – ident: ref66 doi: 10.1053/gast.2003.50053 |
SSID | ssj0000702593 |
Score | 2.522066 |
Snippet | INTRODUCTION Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a threat to public health due to its high morbidity and... KCI Citation Count: 0 |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 276 |
SubjectTerms | Antibodies Antigens Antiviral Agents - therapeutic use chronic hepatitis b Clinical medicine Clinical practice guidelines Committees disease management Guideline Hepatitis B Hepatitis B virus - genetics Hepatitis B, Chronic - drug therapy Humans Infections kasl guidelines Liver cancer Liver cirrhosis Patients therapeutics Transplants & implants treatment 내과학 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JTuQwEC0hDogLYhiWMDDyIMSJiCy24xxhxDJsF0DiZtmOQ7eANOrl_6lK0lE3GsQF9SFSx5aS56q8Krv8DLCP7iMN_kLjyyjkwhXoUsKERnCHfO1S42i-4-ZWXjzwy0fxOHPUF9WENfLADXBHpUMbQRJxsSXykYZHJrbGOW6VF6beR46cN5NM1d_gDLm8VtxNMCUIkyxRjcBmmoroyL3SMkRCUp2KzxFSrduPNFMNy_-FnB8rJ2eo6GwVVtoYkh03z_4DFny1Bks37Sr5Tzi_Or67ZtM9j2y6EYo9TUjTiurcGYaq7LWrfGGDkrlGJZf1PNVYj_sjdrIOD2en938vwvbAhNBhWDIOSblHlHGuTCFji7GTx2whpwqHIs4KlcvMFaUwwnjlufDeKsE5xideYjfLZboBi9Wg8lvALMfBynxUKl_yXCbW0QxRpqLEmxT7BHA4RU27Vk2cDrV40ZhVEMgaQdYEsiaQAzjomr81MhqfNTyhIegakfp1_QfahG5tQn9lEwHs4QDqZ9ev-9P1aaCfhxpzhH86z0kSJw9gZzq-uvXbkU4x3hMp5WgB_Oluo8fRMoqp_GAy0okUNGOENBLAZmMO3eMiRiktjAaQzRnK3PvM36n6vVrVOyf1vIRvfwcAv2CZEG0qjHZgcTyc-F0Mnsb2d-0n75xEE8U priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVkJcEG9SWmQQ4kTUxLEd51R1UUt5tEJApd4sx3G2q7ZJ2cf_ZyZxAosA5RAptqVkxuP5PDP5DPAazUdZvGLr6yQW0lVoUtLGVgqH_tpl1lG84-RUHZ-Jj-fyPATclqGsclgTu4W6ah3FyPcy9MQyI_S8f_MjplOjKLsajtC4DVu4BGs5ga3p4emXr2OUBSc075l3OW4NYp5z3RNtZplM9tw1pSM4UXZqseGYOv5-dDfNov4b9PyzgvI3l3R0H-4FLMkOeuU_gFu-eQh3TkK2_BG8_3Tw7TMb_n1kww9RbLYmbiuqd2cIWdn1WAHD2pq5ni2XXXiqtV7Nl2z6GM6ODr-_O47DwQmxQ3iyionBR9ZpoW2l0hIxlMddQ0GVDlWaV7pQuatqaaX12gvpfamlEIhTvMJhpVDZE5g0beOfASsFKi33Sa19LQrFS0eRolwn3NsMx0TwdpCacYFVnA63uDK4uyAhGxSyISEbEnIEb8buNz2dxr86TkkFYydiwe4etIuZCUZlaofrBwIMl5YETJQViU1L65wotZc2j-AVKtBcunk3nu6z1lwuDO4VPpiiIGqcIoKdQb8m2O_S_JptEbwcm9HyKJ1iG9-ul4YrSZEjdCcRPO2nw_i6KKOMEqQR5BsTZeN7Nlua-UXH7l0Qix4X2_9_redwl2TV1xDtwGS1WPtdhEer8kWwgZ-oVQxc priority: 102 providerName: ProQuest |
Title | KASL clinical practice guidelines for management of chronic hepatitis B |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35430783 https://www.proquest.com/docview/3125534399 https://www.proquest.com/docview/2652027876 https://pubmed.ncbi.nlm.nih.gov/PMC9013624 https://doaj.org/article/fc196661c1b24066a40a1bacc4b8e5a7 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002829249 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Clinical and Molecular Hepatology, 2022, 28(2), , pp.276-331 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RVqp6QbwbKCuDECcCefiRHBDqopby2AoBK-3Nchxnu2qbQHZXgn_PTF6wUC4oh0ixHSXjGc839vgzwBM0H2nw8o0rAp8Lm6NJCeMbwS36axsbS_Mdk1N5MuXvZmL2i1KoE-DyytCOzpOa1hfPv3_78QoN_iVFnLEIXthLWlWIiHkz4Vuwg05JkoJPOqTfDMoKnXtDwRthjOBHKkpaxs2_37AHu7HgMa1vbTirhtMfXVBZF1fB0T-zKn9zU8c34HqHL9lhqxA34Zorb8HupFtBvw1v3h9-_sD6_ZCs3yTF5mviu6IceIYwll0OWTGsKphtGXTZmaP869ViycZ3YHp89OX1id8dpuBbhCwrn1h9RBGmicllmCGuchhJpJT9kIcqT1KpbF4II4xLHBfOZYngHLGLk9gs4zK-C9tlVbp9YBnHjlQuKBJX8FRGmaXZI5UEkTMxtvHgWS81bTumcTrw4kJjxEHy1ihvTfLWJG8Png7Vv7YUG_-qOKYuGCoRM3bzoKrnujM0XVgcUxB02DAjsCIND0yYGWt5ljhhlAePsQP1uV007ek-r_R5rTF-eKvTlOhyUg8O-v7VvUrqGLGgiCl-8-DRUIzWSEsspnTVeqkjKWg2CV2MB_dadRg-t1cqD9SGomz8z2ZJuThrGL9TYtaL-P3_bvkA9kiMbcrRAWyv6rV7iGhqlY1gS83UCHbGR6cfP42aOYlRYzs_ATTWHj0 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VVgJeULnTFjAIeCJq1rFzPFSoCy277CEErdQ34zjOdtU2KXsI8af6G5nJBYuAt2ofIm3sKBnPeE5_A_ASxSfQ-HO1zTxXSJOiSEntaikM6mvja0PxjtE46B2LjyfyZA2umrMwVFbZ7InlRp0WhmLkuz5qYumT9fz28ptLXaMou9q00KjYYmB_fEeXbb7Xf4_r-4rzw4Ojdz237irgGtTdC5fgbWSGvrZOg06CBoZFkzqmMoC0E6ZRHIQmzaSW2kZWSGuTSAqBStwGOC0RgY_PvQEbaGbEKEUb3YPxp89tVAcFiFdIvxxdEZeHPKqAPX1fervmgtIfnCBCI7GiCMt-Aaje8ln2N1P3z4rN31Tg4SbcqW1Xtl8x211Ys_k9uDmqs_P34cNg_8uQNWctWXMAi02WhKVF9fUMTWR20VbcsCJjpkLnZaeWarsX0znrPoDjayHpQ1jPi9w-BpYIZJLQellkMxEHPDEUmQojj1vt4xwH3jRUU6ZGMadmGucKvRkiskIiKyKyIiI78LodflnBd_xrYJeWoB1EqNvlH8VsomohVpnB_QoNGtNJyBAKtPB0J9HGiCSyUocOvMAFVGdmWs6n66RQZzOFvklfxTFB8cQO7DTrq-r9Yq5-cbcDz9vbKOmUvtG5LZZzxQNJkSpUXw48qtihfV2kkU8JWQfCFUZZ-Z7VO_n0tEQTjwm1j4ut_7_WM7jVOxoN1bA_HmzDbaJbVb-0A-uL2dI-QdNskTyt5YHB1-sWwZ9ZlEf9 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=KASL+clinical+practice+guidelines+for+management+of+chronic+hepatitis+B&rft.jtitle=Clinical+and+molecular+hepatology&rft.date=2022-04-01&rft.pub=The+Korean+Association+for+the+Study+of+the+Liver&rft.issn=2287-2728&rft.eissn=2287-285X&rft.volume=28&rft.issue=2&rft.spage=276&rft.epage=331&rft_id=info:doi/10.3350%2Fcmh.2022.0084&rft_id=info%3Apmid%2F35430783&rft.externalDocID=PMC9013624 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-2728&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-2728&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-2728&client=summon |